Skip to main content
. Author manuscript; available in PMC: 2011 Oct 11.
Published in final edited form as: Chronobiol Int. 2011 Oct;28(8):664–672. doi: 10.3109/07420528.2011.601968

FIGURE 5.

FIGURE 5

Acamprosate treatment towards the end of the light-phase of a 24 hr LD cycle [ZT 10] does not affect circadian clock phase. Shown are representative, double-plotted actograms of general circadian locomotor activity prior to and during (black line) a daily regimen of i.p acamprosate treatment (300 mg/kg; A, acamprosate in WT; B, acamprosate in Per2 mutant; C, saline in WT; D, saline in Per2 mutant). Black and white bars represent the 12 hrs of lights-off and lights-on periods, respectively.